v3.26.1
COMMITMENTS AND CONTINGENCIES (Details Narrative)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 10, 2026
USD ($)
Jul. 01, 2024
USD ($)
Oct. 06, 2022
USD ($)
Oct. 03, 2022
Jun. 30, 2012
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2025
ILS (₪)
Jun. 10, 2021
USD ($)
Loss Contingencies [Line Items]                    
Net sales royalty percenatge             3.00%      
Gross proceeds from cash fee percentage       7.00%            
Gross proceeds from management fee percentage       1.00%            
Proceeds from legal settlements           $ 316        
Chief Executive Officer and Executives and Certain Employees [Member]                    
Loss Contingencies [Line Items]                    
Accrued bonuses             $ 604      
Device [Member]                    
Loss Contingencies [Line Items]                    
Royalties percentage     3.00%              
Integrated Product [Member]                    
Loss Contingencies [Line Items]                    
Royalties percentage     1.50%              
At-the-Market Offering Agreement [Member] | Common Stock [Member]                    
Loss Contingencies [Line Items]                    
Aggregate offering $ 39,231 $ 4,820                
Percentage of placement fee   3.00%                
Israeli Innovation Authority [Member]                    
Loss Contingencies [Line Items]                    
Grants receivable               $ 518    
Additional grant from the IIA               $ 673 ₪ 2,153  
Israeli Innovation Authority [Member] | Minimum [Member]                    
Loss Contingencies [Line Items]                    
Net sales royalty percenatge             3.00%      
Israeli Innovation Authority [Member] | Maximum [Member]                    
Loss Contingencies [Line Items]                    
Net sales royalty percenatge             5.00%      
Israeli Innovation Authority [Member] | CardioSert Ltd [Member]                    
Loss Contingencies [Line Items]                    
Repayment of government grants     $ 925              
Ministry of Economy [Member]                    
Loss Contingencies [Line Items]                    
Grants receivable             $ 50      
Technion Research and Development Foundation Limited [Member] | Minimum [Member]                    
Loss Contingencies [Line Items]                    
Net sales royalty percenatge         1.50%          
Technion Research and Development Foundation Limited [Member] | Maximum [Member]                    
Loss Contingencies [Line Items]                    
Net sales royalty percenatge         3.00%          
H.C. Wainwright & Co. LLC [Member]                    
Loss Contingencies [Line Items]                    
Warrants description       The Company has also agreed to issue to Wainwright or its designees preferred investment options upon the closing of such offerings, equal to five (5.0%) percent of the aggregate number of such shares of common stock in such offerings, including upon exercise for cash of any warrants issued to investors in such offering.            
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                    
Loss Contingencies [Line Items]                    
Offering costs                   $ 10,000
Assets consideration     $ 8,000              
2013 Through March 31, 2026 [Member] | Israeli Innovation Authority [Member]                    
Loss Contingencies [Line Items]                    
Revenue from contract with customer, including assessed tax             $ 2,468